M62812 is a drug which acts as a potent and selective antagonist of toll-like receptor 4 (TLR4).

In animal studies it blocks TLR4-mediated cytokine release and has antiinflammatory effects, showing efficacy in animal models of arthritis and septic shock.

[1][2]

This pharmacology-related article is a stub.

You can help Wikipedia by expanding it.